Abstract CN44
Background
Unlike many other countries, Germany does not yet have a national oncological nursing research agenda. This hinders the improvement of research capacity in this important field. Aim: To establish a national oncological nursing agenda for Germany based on research priorities in existing foreign oncological nursing agendas and broad participatory process including nursing experts from all cancer care settings.
Methods
A structured three-step approach was conducted, consisting of a systematic literature research effort to identify potential research topics (1) that would lead to, a standardized online survey of German nurses to prioritize said list (2) before a group of German oncological nursing professionals would revise the findings by formulating clear, and concise definitions and assessing the practicability of the prioritization (3).
Results
From initially 2413 publications 29 publications were included, 55 research topics were extracted from these publications that served as the basis for the survey. The result of the survey (n=174) was that 23 research topics were considered with priority. The expert groups affirmed these priorities. They aligned the linguistic and content of these research priorities and transposed into the agenda. The following topics considered as being most relevant for research were; “effects of illness and therapy”, “specific needs”, “changes due to illness and therapy”, “illness-specific communication”, “information transfer”, “counselling and education”, as well as “quality of life and nursing care at the end of life”.
Conclusions
For the first time in Germany, research topics for oncology nursing are available in a prioritizing agenda. The results show overlapping and complementary findings of current international research agendas and will be an important step to improve research capacity by the new transparency for the inter-professional exchange and information for the funding institutions.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
P. Jahn.
Funding
German Cancer Society.
Disclosure
All authors have declared no conflicts of interest.